<DOC>
	<DOCNO>NCT00292825</DOCNO>
	<brief_summary>The main purpose prevent syncope patient recurrent syncopal episode cause malignant vasovagal faint bradycardia . Patients treat special pacemaker ( closed loop stimulation [ CLS ] ) potentially identify incipient attack prevent syncope pacing .</brief_summary>
	<brief_title>Effect Closed Loop Pacemaker Treatment Recurrent Vasovagal Syncope</brief_title>
	<detailed_description>The treatment patient recurrent syncope vasovagal origin , precipitate usual vasovagal factor , associate structural heart disease , unsolved . The limitation conduct 5 pacemaker study significant placebo effect pacemaker treatment , underpowering lack double blinding . The pacemaker intervention accelerate dual chamber pacing time bradycardia , may late . However , pool data indicate beneficial effect pacing . Vasodilatation obligate element vasovagal syncopal episode many also early sign associate hyperkinetic empty leave ventricle trigger reflex wave . The principle close loop stimulation ( CLS ) continuous surveillance impedance right ventricle correlate highly myocardial contractility . When contractility increase significantly atrial pace prolonged AV delay commence . This principle use chronotropic incompetent patient one small study patient vasovagal syncope positive outcome . The hypothesis CLS potentially identify incipient vasovagal attack able prevent drop cardiac output bradycardia early accelerate pacing . Patients treat 12 month active pacing ( CLS ) cross 12 month passive pacing ( VVI , 30 bpm ) . The study double blind , technician know status pacemaker .</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Syncope , Vasovagal</mesh_term>
	<criteria>A clinical problem vasovagal syncope motivate consideration concern pacemaker treatment . A positive tilttable test . Exclusion cause syncope complete diagnostic workup allow minor cardiac abnormality Syncope &gt; = 2 year . Number syncopal episode &gt; = 3 At least 1 instance syncope within last 6 month . A positive tilttable test reproduces clinical syncope associate clearly abnormal haemodynamic response : Vasovagal Syncope International Study ( VASIS ) type 1 bradycardia &lt; 40 bpm , VASIS type 2A , VASIS type 2B Stable clinical condition Able accept follow protocol give write consent . Conventional indication pacemaker ( i.e . atrioventricular [ AV ] block ) Indication cardiac resynchronisation therapy ( i.e . leave bundle branch block [ LBBB ] ) Documented atrial fibrillation flutter Epilepsy Congestive heart failure History myocardial infarction ( MI ) angina pectoris Serious chronic disease , life expectancy &lt; 3 year . Age &lt; 25 year Pregnant lactating woman Participating investigation</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>vasovagal syncope</keyword>
	<keyword>syncope</keyword>
	<keyword>cardioinhibitory syncope</keyword>
	<keyword>neurocardiogenic syncope</keyword>
	<keyword>pace</keyword>
	<keyword>closed loop pacing</keyword>
	<keyword>tilt table</keyword>
</DOC>